Hypertension, dyslipidemia, and hyperglycemia are common and frequently occurring diseases in medicine, characterized by a wide prevalence and prolonged treatment duration. The number of patients with related metabolic syndromes continues to rise annually, with an increasingly younger age of onset. Particularly in underdeveloped and impoverished regions, where living conditions play a significant role, these diseases are even more prevalent. The high cost of treatment, disease recurrence, and prolonged illness progression have sounded an alarm for both public health and socioeconomic development.

       To further enhance regional capabilities in diagnosing and treating metabolic syndromes and to strengthen healthcare professionals' understanding of chronic metabolic diseases, the Chengdu High-Tech Medical Association has decided to hold the 9th session of "Dyslipidemia, Hyperglycemia, and Hypertension from a Population-Wide Perspective: Management and Challenges of Comorbidities" online on June 28, 2025. The conference will feature lectures by leading experts in the field, along with discussions and exchanges on classic clinical cases and cutting-edge technologies in related specialties.